Homocysteine and post-stroke cognitive decline.
Rowan
Elise N
EN
Institute for Ageing and Health, Newcastle General Hospital, Newcastle upon Tyne, UK. e.n.rowan@ncl.ac.uk
Dickinson
Heather O
HO
Stephens
Sally
S
Ballard
Clive
C
Kalaria
Raj
R
Kenny
Rose Anne
RA
D000368:Aged; D000369:Aged, 80 and over; D001288:Attention; D003071:Cognition; D003072:Cognition Disorders / Q000097:blood / Q000175:diagnosis / Q000209:etiology*; D015331:Cohort Studies; D005500:Follow-Up Studies; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D020138:Hyperhomocysteinemia / Q000097:blood / Q000209:etiology*; D016014:Linear Models; D016015:Logistic Models; D011237:Predictive Value of Tests; D020127:Recovery of Function; D020521:Stroke / Q000097:blood* / Q000150:complications / Q000503:physiopathology / Q000523:psychology; D013997:Time Factors; D014705:Verbal Behavior
D006710:Homocysteine